
|Videos|February 24, 2023
A Cardiologist’s Perspective on Cardiovascular Risk Assessment in Prostate Cancer
Direct insight from a cardiologist on the advent of cardiovascular risk when treating a patient for prostate cancer.
Advertisement
Episodes in this series

January 2023 AbbVie Inc. Company Confidential
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Study shows durable 3-year outcomes with first-line gemcitabine/docetaxel in NMIBC
2
Kathryn Gessner, MD, PhD, on the challenges of selecting patients for bladder preservation
3
Experts discuss the challenge of detecting CIS in bladder cancer
4
First-in-human bladder transplant demonstrates sustained function at 6 months
5



















